GlassScriptPhysician profile
Ryan J Vela
NPI 1487033551
$7,739.13
in general payments reported to CMS, 2019-2025
18 companies · $4,191 in 2025
The $4,191 reported for 2025 was more than what 80% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2020: $305 · 2021: $552 · 2022: $349 · 2023: $935 · 2024: $1,000 · 2025: $4,191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,726 · Travel and Lodging: $1,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,725.93 |
| Travel and Lodging | $1,399.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,829.10 | 2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Tag Conformable Thoracic Stent Graft, Gore Tag Thoracic Branch Endoprosthesis |
| Atricure, INC. | $1,641.39 | 2019-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Abiomed | $910.51 | 2023-2025 | Impella |
| Medtronic, INC. | $625.05 | 2025 | Endurant Iis, Valiant Captivia |
| Medical Device Business Services, INC. | $610.00 | 2020-2021 | |
| Baxter Healthcare | $530.43 | 2023-2025 | Coseal, Starling System, Preveleak |
| Edwards Lifesciences Corporation | $458.16 | 2024-2025 | Evoque, Inspiris Resilia Aortic Valve, Mitris Resilia Mitral Valve |
| Abbott Laboratories | $221.66 | 2021-2024 | Mitraclip |
| Astrazeneca Pharmaceuticals LP | $173.30 | 2024 | Farxiga |
| Tela Bio, INC. | $168.54 | 2022 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $166.02 | 2025 | |
| Tei Biosciences INC | $149.89 | 2019 | |
| Stryker Corporation | $133.33 | 2022 | |
| Lundbeck LLC | $32.85 | 2019-2021 | |
| Pharming Healthcare, INC. | $26.12 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $23.81 | 2021 | |
| Csl Behring | $20.91 | 2022 | |
| Artivion, INC. | $18.06 | 2023 | Amds-Ascyrus Medical, Bioglue Surgical Adhesive, Photofix Decellularized Bovine Pericardium |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Vela listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.